William S. Hambright

1.9k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

William S. Hambright is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, William S. Hambright has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Physiology. Recurrent topics in William S. Hambright's work include Nuclear Structure and Function (7 papers), Muscle Physiology and Disorders (5 papers) and Mesenchymal stem cell research (4 papers). William S. Hambright is often cited by papers focused on Nuclear Structure and Function (7 papers), Muscle Physiology and Disorders (5 papers) and Mesenchymal stem cell research (4 papers). William S. Hambright collaborates with scholars based in United States, China and Japan. William S. Hambright's co-authors include Ren Na, Qitao Ran, Liuji Chen, Rene Solano Fonseca, Johnny Huard, Xiaodong Mu, Paul D. Robbins, Chelsea S. Bahney, Laura J. Niedernhofer and Sudheer Ravuri and has published in prestigious journals such as Journal of Biological Chemistry, PLANT PHYSIOLOGY and The ISME Journal.

In The Last Decade

William S. Hambright

23 papers receiving 1.4k citations

Hit Papers

Ablation of ferroptosis regulator glutathione peroxidase ... 2017 2026 2020 2023 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William S. Hambright United States 15 809 673 440 206 154 23 1.5k
Sho Kobayashi Japan 19 699 0.9× 573 0.9× 430 1.0× 108 0.5× 107 0.7× 40 1.3k
Jianwei Pan China 20 650 0.8× 527 0.8× 428 1.0× 74 0.4× 76 0.5× 68 1.7k
Dominik C. Fuhrmann Germany 18 906 1.1× 378 0.6× 568 1.3× 140 0.7× 56 0.4× 49 1.5k
Huan Luo China 23 676 0.8× 291 0.4× 288 0.7× 78 0.4× 72 0.5× 76 1.3k
Seonghun Kim South Korea 19 686 0.8× 232 0.3× 261 0.6× 323 1.6× 62 0.4× 32 1.3k
Daryl J. Discher United States 13 1.1k 1.4× 159 0.2× 543 1.2× 349 1.7× 136 0.9× 15 1.8k
Shufen Wang China 10 381 0.5× 352 0.5× 253 0.6× 45 0.2× 81 0.5× 31 854
Paul Van Veldhoven Belgium 16 1.0k 1.2× 321 0.5× 323 0.7× 265 1.3× 45 0.3× 25 1.6k

Countries citing papers authored by William S. Hambright

Since Specialization
Citations

This map shows the geographic impact of William S. Hambright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Hambright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Hambright more than expected).

Fields of papers citing papers by William S. Hambright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William S. Hambright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Hambright. The network helps show where William S. Hambright may publish in the future.

Co-authorship network of co-authors of William S. Hambright

This figure shows the co-authorship network connecting the top 25 collaborators of William S. Hambright. A scholar is included among the top collaborators of William S. Hambright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Hambright. William S. Hambright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murata, Yoichi, Michael Mullen, Kohei Yamaura, et al.. (2025). Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells. Journal of Tissue Engineering and Regenerative Medicine. 2025(1). 9187855–9187855. 2 indexed citations
2.
Bricker, Donald L., et al.. (2025). An Examination of the Combined Effects of Multi-Modality Therapy on Cognitive Rehabilitation in Traumatic Brain Injury Patients. International Journal of Clinical Medicine. 16(2). 127–134. 1 indexed citations
3.
Li, Ying, Jie Cui, Lei Liu, et al.. (2024). mtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells. Cell Death and Disease. 15(7). 523–523. 13 indexed citations
5.
Cui, Jie, Lei Liu, Ying Li, et al.. (2023). Nuclear softening mediated by Sun2 suppression delays mechanical stress-induced cellular senescence. Cell Death Discovery. 9(1). 167–167. 17 indexed citations
6.
Hambright, William S., Xiaodong Mu, Xueqin Gao, et al.. (2023). The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model. Journal of Osteoporosis. 2023. 1–12. 27 indexed citations
7.
Mullen, Michael, et al.. (2023). Fisetin Attenuates Cellular Senescence Accumulation During Culture Expansion of Human Adipose-Derived Stem Cells. Stem Cells. 41(7). 698–710. 23 indexed citations
8.
Hambright, William S., et al.. (2022). Cellular expansion of MSCs: Shifting the regenerative potential. Aging Cell. 22(1). e13759–e13759. 45 indexed citations
9.
Liu, Lei, William S. Hambright, Qi Feng, et al.. (2022). Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle. Aging. 14(19). 7650–7661. 27 indexed citations
10.
Liu, Lei, William S. Hambright, Jianming Wei, et al.. (2022). Reduction of senescent fibro‐adipogenic progenitors in progeria‐aged muscle by senolytics rescues the function of muscle stem cells. Journal of Cachexia Sarcopenia and Muscle. 13(6). 3137–3148. 24 indexed citations
11.
Hambright, William S., et al.. (2020). Biologics for Skeletal Muscle Healing: The Role of Senescence and Platelet-Based Treatment Modalities. Operative Techniques in Sports Medicine. 28(3). 150754–150754. 1 indexed citations
12.
Hambright, William S., Marc J. Philippon, & Johnny Huard. (2020). Rapamycin for aging stem cells. Aging. 12(15). 15184–15185. 6 indexed citations
13.
Mu, Xiaodong, Chieh Tseng, William S. Hambright, et al.. (2020). Cytoskeleton stiffness regulates cellular senescence and innate immune response in Hutchinson–Gilford Progeria Syndrome. Aging Cell. 19(8). e13152–e13152. 64 indexed citations
14.
Kawakami, Yohei, William S. Hambright, Koji Takayama, et al.. (2019). Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice. Molecular Therapy — Methods & Clinical Development. 14. 64–76. 35 indexed citations
15.
Hambright, William S., Laura J. Niedernhofer, Johnny Huard, & Paul D. Robbins. (2019). Murine models of accelerated aging and musculoskeletal disease. Bone. 125. 122–127. 20 indexed citations
16.
Hambright, William S., Rene Solano Fonseca, Liuji Chen, Ren Na, & Qitao Ran. (2017). Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biology. 12. 8–17. 648 indexed citations breakdown →
17.
Panchal, Shweta, et al.. (2016). Regulation of Stomatal Defense by Air Relative Humidity. PLANT PHYSIOLOGY. 172(3). 2021–2032. 47 indexed citations
18.
Chen, Liuji, William S. Hambright, Ren Na, & Qitao Ran. (2015). Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. Journal of Biological Chemistry. 290(47). 28097–28106. 382 indexed citations
19.
Ullevig, Sarah L., Hong Seok Kim, William S. Hambright, et al.. (2014). Ursolic acid protects monocytes against metabolic stress-induced priming and dysfunction by preventing the induction of Nox4. Redox Biology. 2. 259–266. 20 indexed citations
20.
Hambright, William S., Stephen Callister, Kristin Burnum-Johnson, et al.. (2013). Development of an ecophysiological model for Diplosphaera colotermitum TAV2, a termite hindgut Verrucomicrobium. The ISME Journal. 7(9). 1803–1813. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026